The North American Menopause Society (NAMS) released its 2017 Hormone Therapy Position Statement (1), which said:
• Hormone therapy (HT) remains the most effective treatment for vasomotor symptoms (like hot flashes), problems with the genitourinary tract, and has been shown to prevent bone loss and fracture.
• The risks of HT differ depending on the specific hormone, dose, duration of use, route of administration, timing of initiation, and which type of progestogen (i.e., synthetic progestin or natural progesterone) is used.
• Treatment should be individualized to maximize benefits and minimize risks.